Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Peter S. García
Age : 60
Public asset : 552,015 USD
Linked companies : ALX Oncology Holdings Inc. - DURECT Corporation
Summary 
Peter S. García holds the position of Chief Financial Officer for ALX Oncology Holdings, Inc.

He is also on the board of DURECT Corp., Moraga Biotechnology Corp. and Noden Pharma USA, Inc.

In his past career he was CFO, Head-Investor & Media Relations at Lineage Cell Therapeutics, Inc. and Chief Financial Officer for Asterias Biotherapeutics, Inc. (a subsidiary of Lineage Cell Therapeutics, Inc.), Chief Financial Officer at Nanosys, Inc., Chief Financial Officer & Vice President of PDL BioPharma, Inc., Chief Financial Officer, Secretary & IR Contact at Adhera Therapeutics, Inc. and Chief Financial Officer & Secretary of MDRNA, Inc. (a subsidiary of Adhera Therapeutics, Inc.), Chief Financial Officer for Novacept, Inc., Principal at Amgen, Inc., Principal at Teradata Corp., Chief Financial Officer & Senior Vice President of Nuvelo, Inc., Chief Financial Officer of IntraBiotics Pharmaceuticals, Inc., Chief Financial Officer for Dendreon Corp. and Chief Financial Officer for CYTYC Surgical Products.

He received an MBA from the University of California, Los Angeles and an undergraduate degree from Stanford University.


Current positions of Peter S. García 
NameTitle Since
DURECT Corporation
(Biotechnology & Medical Research)
Independent Director -
ALX Oncology Holdings Inc.
(Biotechnology & Medical Research)
Chief Financial Officer 2021
Moraga Biotechnology Corp. Director -
Noden Pharma USA, Inc. Director -


Holdings of Peter S. García 
NameEquities%Valuation
ALX Oncology Holdings Inc. (ALXO)
(Biotechnology & Medical Research)
53,4830.13%517,715 USD
DURECT Corporation (DRRX)
(Biotechnology & Medical Research)
70,0000.031%34,300 USD


Peter S. García: Personal Network 
Most Read News 
08/06ELON MUSK : Musk says Twitter deal should go ahead if it provides proof of real accounts
RE
08/09ELON MUSK : Elon Musk sells 7.92 million Tesla shares worth $6.9 billion - SEC filing
RE
08/12MASAYOSHI SON : With Alibaba stake cut, SoftBank's Son cools toward China tech
RE
08/04JACK DORSEY : Dorsey-led Block posts loss for second quarter
RE
08/02ELON MUSK : Twitter queries banks on Musk's attempts to undermine $44 billion deal
RE
08/01DAVID EINHORN : Einhorn's Greenlight takes stake in Twitter - letter
RE
08/02STEPHEN KING : Horror author Stephen King says in publishing trial that consolidation hurts competition
RE
10:52aANSHU JAIN : Former Deutsche Bank co-CEO Anshu Jain dies - Bloomberg News
RE
08/01STEPHEN KING : Stephen King goes to bat for U.S. gov't in case against book publishing mega-merger
RE
08/04ELON MUSK : Twitter rejects Musk's claims that he was hoodwinked
RE
More news


© 2022 People and Ownership :   
Peter S. García : Connections